Product: Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.
Reason for recall: Subpotent drug; Clavulanate Potassium component
Recall initiated: 20251013
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated